| 26 |
Editorial Mesothelioma: benefit from surgical resection is questionable. 2007
Treasure T, Utley M. · No affiliation provided · J Thorac Oncol. · Pubmed #17909347 No free full text.
This publication has no abstract.
|
| 27 |
Editorial [Asbestos in France] 2007
Frija J, Fournier M. · No affiliation provided · Rev Mal Respir. · Pubmed #17632429 No free full text.
This publication has no abstract.
|
| 28 |
Editorial Hunting for a pleural fluid test for mesothelioma: is soluble mesothelin the answer? 2007
Lee YC. · No affiliation provided · Thorax. · Pubmed #17600291 No free full text.
This publication has no abstract.
|
| 29 |
Editorial Chemotherapy in malignant mesothelioma: what's up, doc? 2006
van Meerbeeck JP. · No affiliation provided · J Thorac Oncol. · Pubmed #17409869 No free full text.
This publication has no abstract.
|
| 30 |
Editorial [The experts' conference of the Société de Pneumologie de Langue Française (SPLF) on malignant pleural mesothelioma (MPM): useful and necessary recommendations] 2006
Scherpereel A. · No affiliation provided · Rev Mal Respir. · Pubmed #17370375 No free full text.
This publication has no abstract.
|
| 31 |
Editorial Environmental asbestos contamination: What are the risks? free! 2007
Roggli VL. · No affiliation provided · Chest. · Pubmed #17296628 links to free full text
This publication has no abstract.
|
| 32 |
Editorial A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma. free! 2007
Rusch VW. · No affiliation provided · Eur J Cardiothorac Surg. · Pubmed #17267238 links to free full text
This publication has no abstract.
|
| 33 |
Editorial Peritoneum as the first-line of defense in carcinomatosis. 2007
Sugarbaker PH. · No affiliation provided · J Surg Oncol. · Pubmed #17262739 No free full text.
This publication has no abstract.
|
| 34 |
Editorial Malignant mesothelioma: A disease that continues to mystify. free! 2006
Bendayan D, Kramer MR. · No affiliation provided · Isr Med Assoc J. · Pubmed #16889169 links to free full text
This publication has no abstract.
|
| 35 |
Editorial Current trends in the management of malignant pleural mesothelioma. 2006
Tsiouris A, Gourgoulianis KI, Walesby RK. · No affiliation provided · Expert Rev Anticancer Ther. · Pubmed #16761925 No free full text.
This publication has no abstract.
|
| 36 |
Editorial Moving knowledge of global burden into preventive action. 2005
Eijkemans GJ, Takala J. · No affiliation provided · Am J Ind Med. · Pubmed #16299702 No free full text.
Abstract: BACKGROUND: Estimation of the global burden of disease and injury due to selected occupational factors is a topic of interest to policy makers, governments, and international bodies. The World Health Organization (WHO) has implemented a Comparative Risk Assessment (CRA) to estimate risk to exposed populations. METHODS: Estimates of the risk factor-burden relationships by age, sex, and WHO subregion were generated. Risk measurements (relative risks and mortality rates) for the health outcomes were determined primarily from studies published in peer review journals. The resulting burden was described as the attributable fraction of disease or injury, using both mortality and disability-adjusted life years (DALYs). RESULTS: The papers in this issue include discussions of worldwide mortality and morbidity from lung cancer, leukemia, and malignant mesothelioma arising from occupational exposures; mortality and morbidity from asthma, COPD, and pneumoconiosis; the global burden of low back pain; exposure to contaminated sharps injuries among health care workers; noise-induced hearing loss; and occupational injuries. Three papers focus on economic issues: estimation of net-costs for prevention of occupational low back pain; cost effectiveness of occupational health interventions; and the cost effectiveness of interventions in the prevention of silicosis. CONCLUSIONS: The magnitude of the occupational health burden in the world is overwhelming, and the causes and mechanisms are multiple and complex. Commitment from all stakeholders is imperative to translate economic progress into sustainable human development and well-being.
|
| 37 |
Editorial Mesothelioma versus carcinoma: getting easier? 2005
Battifora H. · No affiliation provided · Hum Pathol. · Pubmed #16260266 No free full text.
This publication has no abstract.
|
| 38 |
Editorial Serum osteopontin levels--is it time to screen asbestos-exposed workers for pleural mesothelioma? 2005
Cullen MR. · No affiliation provided · N Engl J Med. · Pubmed #16221786 No free full text.
This publication has no abstract.
|
| 39 |
Editorial Can exposure to very low levels of asbestos induce pleural mesothelioma? free! 2005
Goldberg M, Luce D. · No affiliation provided · Am J Respir Crit Care Med. · Pubmed #16216834 links to free full text
This publication has no abstract.
|
| 40 |
Editorial The medical record on trial: was it mesothelioma or lung cancer ... or another frivolous lawsuit? 2005
Radak JT. · No affiliation provided · Geriatrics. · Pubmed #16153138 No free full text.
This publication has no abstract.
|
| 41 |
Editorial Do we need two more mesothelial markers? 2005
Battifora HA, Gown AM. · No affiliation provided · Hum Pathol. · Pubmed #15948109 No free full text.
This publication has no abstract.
|
| 42 |
Editorial Malignant mesothelioma. 2004
Davidson B, Suo Z, Nesland JM. · No affiliation provided · Ultrastruct Pathol. · Pubmed #15693629 No free full text.
This publication has no abstract.
|
| 43 |
Editorial Second Heidelberg Thoracic Oncology Symposium on the Diagnosis and Treatment of Pleural Mesothelioma--introduction. 2004
Thatcher N. · No affiliation provided · Lung Cancer. · Pubmed #15261424 No free full text.
This publication has no abstract.
|
| 44 |
Editorial Malignant pleural mesothelioma: the puzzling role of gene-environment interaction. free! 2004
Di Maria GU, Comba P. · No affiliation provided · Chest. · Pubmed #15136364 links to free full text
This publication has no abstract.
|
| 45 |
Editorial ["Crossing Jordan"--pleural mesothelioma evolving as a treatable disease] 2004
Eberhardt W. · No affiliation provided · Pneumologie. · Pubmed #15098156 No free full text.
This publication has no abstract.
|
| 46 |
Editorial Radical surgery for mesothelioma. free! 2004
Treasure T, Waller D, Swift S, Peto J. · No affiliation provided · BMJ. · Pubmed #14751871 links to free full text
This publication has no abstract.
|
| 47 |
Editorial Mesothelioma as marker of both exposures and effects. 2003
Gennaro V, Montanaro F. · No affiliation provided · Monaldi Arch Chest Dis. · Pubmed #14635496 No free full text.
This publication has no abstract.
|
| 48 |
Editorial Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care? 2003
Rusch VW. · No affiliation provided · J Clin Oncol. · Pubmed #12860935 No free full text.
This publication has no abstract.
|
| 49 |
Editorial Radical surgery for mesothelioma: how can we obtain evidence? 2003
Treasure T, Swift S, Tan C. · No affiliation provided · World J Surg. · Pubmed #12784152 No free full text.
Abstract: Asbestos exposure in industry and construction sites in the 1960s and 1970s has left a legacy of mesothelioma, a diffuse pleural cancer, with a lag time of 40 to 50 years and due to peak around 2015 to 2020. Some surgeons believe that by radical surgery they can prolong life and relieve symptoms, but the evidence comes from very carefully selected series. How do surgeons respond to demand for evidence of benefit? In this article we explore how evidence for major surgical operations has been gained and how mesothelioma fits into this history.
|
| 50 |
Editorial 18F-FDG imaging of malignant pleural mesothelioma: scientiam impendere vero... 2003
Gerbaudo VH. · No affiliation provided · Nucl Med Commun. · Pubmed #12766595 No free full text.
This publication has no abstract.
|
Prior · Next |